CardioMech
CardioMech is dedicated to designing new therapeutic options for heart disease, focusing on innovative catheter-based therapies for conditions like Mitral Regurgitation. Their goal is to provide simple, effective, and less invasive treatment options to reduce the need for open-heart surgery and improve patient outcomes.
Industries
Biotechnology
Health Care
Medical
Medical Device
Medical Equipment Manufacturing
Nr. of Employees
small (1-50)
Patents
Products
Percutaneous artificial chordae implant (investigational)
An investigational catheter-delivered implant designed to replace or augment mitral valve chordae to reduce regurgitation and restore native valve function.
CardioMech MVRS
A transcatheter mitral valve repair solution designed to deliver artificial chordae tendineae via a transfemoral, transseptal approach on a beating heart.
Percutaneous artificial chordae implant (investigational)
An investigational catheter-delivered implant designed to replace or augment mitral valve chordae to reduce regurgitation and restore native valve function.
CardioMech MVRS
A transcatheter mitral valve repair solution designed to deliver artificial chordae tendineae via a transfemoral, transseptal approach on a beating heart.
Expertise Areas
- Transcatheter mitral valve repair
- Percutaneous structural heart device development
- Minimally invasive cardiac device design
- Clinical evaluation of investigational cardiovascular devices
Key Technologies
- Catheter-based delivery systems
- Artificial chordae implants
- Transcatheter structural heart devices
- Percutaneous chordal repair techniques